National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges
Douglas C. Bauer(University of California, San Francisco), Susan Randall(Bone Health and Osteoporosis Foundation), Gary L. Myers(Centers for Disease Control and Prevention), Nancy E. Lane(University of California, Davis), Hubert W. Vesper(National Center for Environmental Health), John H. Krege(Eli Lilly (United States)), Eileen Leary(Pacific Biomarkers (United States)), D. Lee(Digital Research Alliance of Canada), Paul D. Miller(Colorado Center for Bone Research), M Payette(Roche (Switzerland)), S Silverman(Cedars-Sinai Medical Center), Cesar Libanati(Amgen (United States))
Cited by 153
Related Papers
Markers of Inflammation and Cardiovascular Disease
|Circulation|2003|6.3k
Clinician’s Guide to Prevention and Treatment of Osteoporosis
|Osteoporosis International|2014|4.1k
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2009|3.4k
Generation and reproductive phenotypes of mice lacking estrogen receptor β
|Proceedings of the National Academy of Sciences|1998|1.7k